Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Oiso

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pharmaceutics|February 29, 2020
Method for Pulmonary Administration Using Negative Pressure Generated by Inspiration in MiceYuki Oiso, Tomomi Akita, Daiki Kato, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 11, 2015
Pulmonary administration of phosphoinositide 3-kinase inhibitor is a curative treatment for chronic obstructive pulmonary disease by alveolar regenerationMichiko Horiguchi, Yuki Oiso, Hitomi Sakai, et al.
Biological & Pharmaceutical Bulletin|May 7, 2016
Pulmonary Administration of GW0742, a High-Affinity Peroxisome Proliferator-Activated Receptor Agonist, Repairs Collapsed Alveoli in an Elastase-Induced Mouse Model of EmphysemaChihiro Ozawa, Michiko Horiguchi, Tomomi Akita, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 23, 2017
Effect of 4-[(5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-2-Naphthalenyl)Carbamoyl]Benzoic Acid (Am80) on Alveolar Regeneration in Adiponectin Deficient-Mice Showing a Chronic Obstructive Pulmonary Disease-Like PathophysiologyHitomi Sakai, Michiko Horiguchi, Tomomi Akita, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pharmaceutics|February 29, 2020
Method for Pulmonary Administration Using Negative Pressure Generated by Inspiration in MiceYuki Oiso, Tomomi Akita, Daiki Kato, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 11, 2015
Pulmonary administration of phosphoinositide 3-kinase inhibitor is a curative treatment for chronic obstructive pulmonary disease by alveolar regenerationMichiko Horiguchi, Yuki Oiso, Hitomi Sakai, et al.
Biological & Pharmaceutical Bulletin|May 7, 2016
Pulmonary Administration of GW0742, a High-Affinity Peroxisome Proliferator-Activated Receptor Agonist, Repairs Collapsed Alveoli in an Elastase-Induced Mouse Model of EmphysemaChihiro Ozawa, Michiko Horiguchi, Tomomi Akita, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 23, 2017
Effect of 4-[(5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-2-Naphthalenyl)Carbamoyl]Benzoic Acid (Am80) on Alveolar Regeneration in Adiponectin Deficient-Mice Showing a Chronic Obstructive Pulmonary Disease-Like PathophysiologyHitomi Sakai, Michiko Horiguchi, Tomomi Akita, et al.
Pageof 1